Advanced Cell Technology, Inc. (“ACT”; OTCBB: ACTC)
is a biotechnology company that specializes in the development of cellular therapies for the treatment of diseases and conditions that impact tens of millions of people worldwide. The company applies stem cell-based technologies (both for adult and “embryo-safe” human embryonic stem cells) and other proprietary methods in the field of regenerative medicine to bring patient-specific therapies from the lab bench to the bedside.
EventsApril 3, 2014
ACT Corporate Update, Conference Call & Webcast March 26, 2014
ARM’s Regen Med Investor Day, New York, NY